skip to main content
Idioma:
Refinado por: assunto: Ensaio Clínico Controlado Randomizado remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042) a randomised, open-label, controlled, phase 3 trial
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042) a randomised, open-label, controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042) a randomised, open-label, controlled, phase 3 trial

Tony S. K Mok Yi-Long Wu; Iveta Kudaba; Dariusz M Kowalski; Byoung Chul Cho; Hande Z Turna; Gilberto de Castro Junior; Vichien Srimuninnimit; Konstantin K Laktionov; Igor Bondarenko

Lancet v. 393, n. 10183, p. 1819-1830, 2019

New York 2019

Acesso online. A biblioteca também possui exemplares impressos.

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.